Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria

被引:28
|
作者
Sampurno, Fanny [1 ]
Earnest, Arul [1 ]
Kumari, Patabendi B. [1 ]
Millar, Jeremy L. [2 ]
Davis, Ian D. [3 ]
Murphy, Declan G. [4 ]
Frydenberg, Mark [5 ,6 ]
Kearns, Paul A. [6 ]
Evans, Sue M. [1 ]
机构
[1] Monash Univ, Melbourne, Vic, Australia
[2] Alfred Hlth, Melbourne, Vic, Australia
[3] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Monash Hlth, Melbourne, Vic, Australia
[6] Geelong Urol, Melbourne, Vic, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
POSITIVE SURGICAL MARGINS; RADICAL PROSTATECTOMY; PATHOLOGICAL OUTCOMES; ACTIVE SURVEILLANCE; DIAGNOSIS; IMPACT; RISK; MEN; IMPROVEMENT; SPECIMENS;
D O I
10.5694/mja15.01041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyse the performance of the quality of prostate cancer (CaP) care over a 5-year period with reference to three quality indicators (QIs) reported by the Prostate Cancer Outcomes Registrye-Victoria (PCOR-Vic): QI-1: Alignment with the modified Prostate Cancer Research International Active Surveillance (PRIAS) protocol guideline; QI-2: Timeliness of CaP care for men with high risk and locally advanced disease; QI-3: Positive surgical margins (PSMs) for organ-confined pathological T2 disease. Design, setting and participants: Between 1 January 2009 and 31 December 2013, 4708 men diagnosed with CaP who met the QI-1, QI-2 or QI-3 inclusion criteria were recruited from Victorian hospitals. Outcome measures and statistical analysis: Trend analysis was conducted to monitor performance according to QI-1, QI-2 and QI-3. We used the autoregressive integrated moving average (ARIMA) model to account for any inherent autocorrelation in the data when analysing the monthly incidence of each indicator. Differences in the annual figures for the indicators across years were also analysed by aggregating data by year and applying the ARIMA model. Results and limitations: There was a downward trend over the 5 years in the percentage of men with low risk disease who underwent active treatment (45% to 34%; P = 0.024), an upward trend in the percentage of those with high risk and locally advanced disease who received active treatment within 12 months of diagnosis (88% to 93%; P = 0.181), and a decline in PSM rate in men with pathological T2 disease after radical prostatectomy (21% to 12%; P = 0.036). Limitations of the study include the fact that the improvement in the QIs was detected using PCOR-Vic as a single population, but there may be institutional variations in quality improvement. Conclusions: Over 2009-2013, the performance of the Victorian health system improved according to the three processes of care indicators reported by the PCOR-Vic.
引用
收藏
页码:319.e1 / 319.e7
页数:7
相关论文
共 50 条
  • [1] Prostate cancer outcomes and delays in care
    O'Callaghan, Michael E.
    Shi, Zumin
    Kopsaftis, Tina
    Moretti, Kim
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 449 - 455
  • [2] Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update
    Wang, Luke L.
    Begashaw, Kirobel
    Evans, Melanie
    Earnest, Arul
    Evans, Sue M.
    Millar, Jeremy L.
    Murphy, Declan G.
    Moon, Daniel
    ANZ JOURNAL OF SURGERY, 2018, 88 (10) : 1037 - 1042
  • [3] The Prostate Cancer Registry: monitoring patterns and quality of care for men diagnosed with prostate cancer
    Evans, Sue M.
    Millar, Jeremy L.
    Wood, Julie M.
    Davis, Ian D.
    Bolton, Damien
    Giles, Graham G.
    Frydenberg, Mark
    Frauman, Albert
    Costello, Antony
    McNeil, John J.
    BJU INTERNATIONAL, 2013, 111 (4B) : E158 - E166
  • [4] Androgen deprivation therapy use with post-prostatectomy radiotherapy in the Prostate Cancer Outcomes Registry Victoria
    Ong, Wee Loon
    Foroudi, Farshad
    Evans, Sue
    Millar, Jeremy
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2019, 63 (01) : 124 - 130
  • [5] Prospective evaluation of patient-reported quality of life outcomes after external beam radiation treatment for prostate cancer in Victoria: A cohort study by the Victorian Prostate Cancer Registry
    Bandarage, Varuni Ransika Kumari Patabendi
    Billah, Baki
    Millar, Jeremy L.
    Evans, Sue
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2016, 60 (03) : 420 - 427
  • [6] Impact of Age on Quality-of-life Outcomes After Treatment for Localized Prostate Cancer
    Hampson, Lindsay A.
    Cowan, Janet E.
    Zhao, Shoujun
    Carroll, Peter R.
    Cooperberg, Matthew R.
    EUROPEAN UROLOGY, 2015, 68 (03) : 480 - 486
  • [7] Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
    Lardas, Michael
    Liew, Matthew
    van den Bergh, Roderick C.
    De Santis, Maria
    Bellmunt, Joaquim
    Van den Broeck, Thomas
    Cornford, Philip
    Cumberbatch, Marcus G.
    Fossati, Nicola
    Gross, Tobias
    Henry, Ann M.
    Bolla, Michel
    Briers, Erik
    Joniau, Steven
    Lam, Thomas B.
    Mason, Malcolm D.
    Mottet, Nicolas
    van der Poel, Henk G.
    Rouviere, Olivier
    Schoots, Ivo G.
    Wiegel, Thomas
    Willemse, Peter-Paul M.
    Yuan, Cathy Yuhong
    Bourke, Liam
    EUROPEAN UROLOGY, 2017, 72 (06) : 869 - 885
  • [8] Development of an International Prostate Cancer Outcomes Registry
    Evans, Sue M.
    Nag, Nupur
    Roder, David
    Brooks, Andrew
    Millar, Jeremy L.
    Moretti, Kim L.
    Pryor, David
    Skala, Marketa
    McNeil, John J.
    BJU INTERNATIONAL, 2016, 117 : 60 - 67
  • [9] Technology Diffusion and Prostate Cancer Quality of Care
    Schroeck, Florian R.
    Kaufman, Samuel R.
    Jacobs, Bruce L.
    Skolarus, Ted A.
    Zhang, Yun
    Hollenbeck, Brent K.
    UROLOGY, 2014, 84 (05) : 1066 - 1072
  • [10] PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness
    Paller, Channing J.
    Barata, Pedro C.
    Lorentz, Justin
    Appleman, Leonard J.
    Armstrong, Andrew J.
    DeMarco, Tiffani A.
    Dreicer, Robert
    Elrod, Jo Ann B.
    Fleming, Mark
    George, Christopher
    Heath, Elisabeth I.
    Hussain, Maha H. A.
    Mao, Shifeng
    McKay, Rana R.
    Morgans, Alicia K.
    Orton, Matthew
    Pili, Roberto
    Riedel, Elyn
    Saraiya, Biren
    Sigmond, Joelle
    Sokolova, Alexandra
    Stadler, Walter M.
    Tran, Christina
    Macario, Natalie
    Vinson, Jacob
    Green, Rebecca
    Cheng, Heather H.
    PROMISE Trial Investigators
    PROSTATE, 2024, 84 (03) : 292 - 302